₹39.75
+₹1.85 (+4.88%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹15 Cr
P/E
9.43
ROE
9.36%
ROCE
11.66%
About Saroja Pharma Industries India Ltd
Saroja Pharma Industries India in trading, exporting, and supplying Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, and Specialty Chemicals for human and veterinary use. They cater to pharmaceutical companies in India and internationally, offering customized products and contributing to cost-effective medicine production.
Founded
2019
CEO
Biju Gopinathan Nair
Employees
12
HQ
Mumbai, India
About Saroja Pharma Industries India Ltd
Saroja Pharma Industries India in trading, exporting, and supplying Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, and Specialty Chemicals for human and veterinary use. They cater to pharmaceutical companies in India and internationally, offering customized products and contributing to cost-effective medicine production.
Founded:2019
CEO:Biju Gopinathan Nair
Employees:12
HQ:Mumbai, India
Finished Products
1Sales
₹93.80Cr2Consultancy Service
₹0.60CrRaw Materials
1Cost of Materials Consumed
₹80.45CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹52
52W Low
₹28
Volume9.60K
Avg VolumeN/A
Beta0.55
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
9.43x
Valuation
P/B Ratio
0.88x
Valuation
EPS
₹4.02
Valuation
Dividend Yield
0.00%
Valuation
ROE
9.36%
Profitability
ROCE
11.66%
Profitability
Revenue by Segment
Contribution & growth by business line
Chemicals like Thionyl Chloride AndRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
91.5%
International
8.5%
INDIA91.5%
ASIA PACIFIC8.5%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.83x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
2.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.